Insights

Strategic Partnerships Reithera has established collaborations with industry leaders like SillaJen, Trellis Research Group, and the Sabin Vaccine Institute, highlighting opportunities to offer tailored manufacturing solutions and expand joint R&D initiatives in advanced gene therapies and vaccines.

Rapid Clinical Support The company's involvement in manufacturing for phase two trials and vaccine distribution demonstrates a capacity to support accelerated clinical programs, making it a valuable partner for organizations seeking reliable GMP production for cutting-edge therapies.

Innovative Manufacturing Reithera's focus on scalable viral vector manufacturing, including AAVs and other vectors, creates opportunities to provide scalable, cost-effective production services to biotech firms developing gene therapies and viral-based medicines.

Global Development With initiatives to develop affordable vaccines for low- and middle-income countries, Reithera is positioned as a partner for organizations aiming to expand global health initiatives through scalable and economical production solutions.

Technology Leadership Reithera's advanced GMP infrastructure, with large-scale bioreactors and expertise in viral vector processes, allows it to meet high-quality manufacturing demands, presenting opportunities for sales of high-capacity production services and technical collaborations.

Similar companies to REITHERA

REITHERA Tech Stack

REITHERA uses 8 technology products and services including Open Graph, Google Cloud, jQuery Migrate, and more. Explore REITHERA's tech stack below.

  • Open Graph
    Content Management System
  • Google Cloud
    Infrastructure As A Service
  • jQuery Migrate
    Javascript Libraries
  • SiteGround
    Platform As A Service
  • Cloudflare Bot Management
    Security
  • Google Tag Manager
    Tag Management
  • WPML
    Web Platform Extensions
  • ExactMetrics
    Web Platform Extensions

Media & News

REITHERA's Email Address Formats

REITHERA uses at least 1 format(s):
REITHERA Email FormatsExamplePercentage
First.Last@reithera.comJohn.Doe@reithera.com
88%
F.Last@reithera.comJ.Doe@reithera.com
6%
First.MiddleLast@reithera.comJohn.MichaelDoe@reithera.com
4%
Last@reithera.comDoe@reithera.com
2%

Frequently Asked Questions

Where is REITHERA's headquarters located?

Minus sign iconPlus sign icon
REITHERA's main headquarters is located at 100 Viaduct di Castel Romano Roma, Lazio 00128 Italy. The company has employees across 2 continents, including EuropeNorth America.

What is REITHERA's official website and social media links?

Minus sign iconPlus sign icon
REITHERA's official website is reithera.com and has social profiles on LinkedInCrunchbase.

What is REITHERA's SIC code NAICS code?

Minus sign iconPlus sign icon
REITHERA's SIC code is 8733 - Noncommercial Research Organizations NAICS code is 541714 - Research and Development in Biotechnology (except Nanobiotechnology).

How many employees does REITHERA have currently?

Minus sign iconPlus sign icon
As of April 2026, REITHERA has approximately 161 employees across 2 continents, including EuropeNorth America. Key team members include Chief Executive Officer: S. C.Head Of Business Development: C. P.Head Of Business Development - U.S: T. D. M.. Explore REITHERA's employee directory with LeadIQ.

What industry does REITHERA belong to?

Minus sign iconPlus sign icon
REITHERA operates in the Biotechnology Research industry.

What technology does REITHERA use?

Minus sign iconPlus sign icon
REITHERA's tech stack includes Open GraphGoogle CloudjQuery MigrateSiteGroundCloudflare Bot ManagementGoogle Tag ManagerWPMLExactMetrics.

What is REITHERA's email format?

Minus sign iconPlus sign icon
REITHERA's email format typically follows the pattern of First.Last@reithera.com. Find more REITHERA email formats with LeadIQ.

How much funding has REITHERA raised to date?

Minus sign iconPlus sign icon
As of April 2026, REITHERA has raised $1.4M in funding. The last funding round occurred on Nov 03, 2021 for $1.4M.

When was REITHERA founded?

Minus sign iconPlus sign icon
REITHERA was founded in 2005.

REITHERA

Biotechnology ResearchLazio, Italy51-200 Employees

ReiThera Srl is a CDMO company dedicated to technology and process development and GMP manufacturing, providing support for the clinical translation of genetic vaccines and medicinal products for advanced therapies. 
The company has extensive expertise in developing scalable processes for viral-vector manufacturing and a consolidated experience in GMP production of Adeno-Associated Vector (AAV), Lentivirus, Adeno Viral vector (AdV), Modified Vaccinia Ankara and Herpes Simplex Vector. 
ReiThera's core manufacturing capacity is based in a state-of-the-art facility, which includes stirred-tank bioreactors at scales of 50L, 200L, 1000L, and 2000L, as well as fixed-bed bioreactors for cell growth in adherence. The GMP facility also comprises a filling suite and quality control laboratories. 
ReiThera's headquarters, R&D laboratories, and GMP facilities are located in Rome, Italy. 
For more information, visit www.reithera.com

Section iconCompany Overview

Headquarters
100 Viaduct di Castel Romano Roma, Lazio 00128 Italy
SIC Code
8733 - Noncommercial Research Organizations
NAICS Code
541714 - Research and Development in Biotechnology (except Nanobiotechnology)
Founded
2005
Employees
51-200

Section iconFunding & Financials

  • $1.4M

    REITHERA has raised a total of $1.4M of funding over 1 rounds. Their latest funding round was raised on Nov 03, 2021 in the amount of $1.4M.

  • $1M$10M

    REITHERA's revenue is estimated to be in the range of $1M$10M

Section iconFunding & Financials

  • $1.4M

    REITHERA has raised a total of $1.4M of funding over 1 rounds. Their latest funding round was raised on Nov 03, 2021 in the amount of $1.4M.

  • $1M$10M

    REITHERA's revenue is estimated to be in the range of $1M$10M

Ready to create more pipeline?

Get a demo and discover why thousands of SDR and Sales teams trust
LeadIQ to help them build pipeline confidently.

© LeadIQ, Inc. All rights reserved.